Developing CuS for Predicting Aggressiveness and Prognosis in Lung Adenocarcinoma

Area of Science:

• Oncology
• Cell Death Mechanisms
• Molecular Biology

Background:

• Cuproptosis is an emerging cell death pathway regulated by copper ionophores.
• Cuproptosis-related genes (CRGs) are implicated in various cancer types and tumor characteristics.
• The role of cuproptosis in lung adenocarcinoma (LUAD) requires further investigation.

Purpose of the Study:

• To investigate the involvement of cuproptosis in LUAD.
• To develop a cuproptosis-related score (CuS) for predicting LUAD aggressiveness and prognosis.
• To identify potential therapeutic targets for LUAD patients with high CuS.

Main Methods:

• Construction and validation of the cuproptosis-related score (CuS) using LUAD datasets.
• Correlation analysis between CuS and clinical features, tumor characteristics, and immune/mitochondrial pathways.
• Drug sensitivity prediction for patients with high CuS.

Main Results:

• CuS demonstrated superior predictive performance for LUAD prognosis compared to individual CRGs.
• High CuS was significantly associated with poor prognosis in LUAD patients.
• CuS correlated with immune and mitochondrial pathways, suggesting functional links.
• Six potential drugs, including AZD3759, were identified for targeting high-CuS LUAD.

Conclusions:

• Cuproptosis plays a role in LUAD aggressiveness.
• The CuS is a valuable tool for predicting LUAD patient prognosis and guiding precise treatment.
• These findings support the therapeutic potential of targeting cuproptosis in LUAD.